See All Slides - tctmd.com

Slides

Presentation

CABG Surgery vs DES for Patients with Isolated Proximal LAD Disease

Presenter: Edward L. Hannan

December 22, 2014

Presentation

Of 7,372 patients from the ORBIT-AF registry treated with oral anticoagulants, 2,200 had at least 1 interruption and bridging was used in 24%_

Presenter: Benjamin A. Steinberg

December 22, 2014

Presentation

Beyond the Early Stages: Insights from the ASSURE Registry on Bioresorbable Vascular Scaffolds

Presenter: J. W?hrle

December 21, 2014

Presentation

Fenestrated EVAR is Associated with Increased Morbidity but Comparable Mortality with Infrarenal EVAR

Presenter: N.O Glebova

December 18, 2014

Presentation

Incidence, Predictors, and Prognostic Impact of Late Bleeding Complications After TAVR

Presenter: P. G?n?reux

December 16, 2014

Presentation

A Randomized Trial of Intraarterial Treatment for Acute Ischemic Stroke

Presenter: O.A. Berkhemer

December 16, 2014

Presentation

Relationship Between Inflammation and Benefits of Early High-Dose Rosuvastatin on CIN in ACS Patients

Presenter: Anna Toso

December 15, 2014

Presentation

DCB vs Standard PTA for the Treatment of Superficial Femoral and-or Popliteal PAD

Presenter: G. Tepe

December 15, 2014

Presentation

Stent Coverage and Neointimal Proliferation in BMS Postdilated With a Paclitaxel-Eluting Balloon vs EES

Presenter: T.C. Poerner

December 14, 2014

Presentation ICI 2014

ACS 2014: Unmet Needs

Presenter: Yoseph Rozenman

December 14, 2014

Advertisement

Slides

CABG Surgery vs DES for Patients with Isolated Proximal LAD Disease

Of 7,372 patients from the ORBIT-AF registry treated with oral anticoagulants, 2,200 had at least 1 interruption and bridging was used in 24%_

Beyond the Early Stages: Insights from the ASSURE Registry on Bioresorbable Vascular Scaffolds

Fenestrated EVAR is Associated with Increased Morbidity but Comparable Mortality with Infrarenal EVAR

Incidence, Predictors, and Prognostic Impact of Late Bleeding Complications After TAVR

A Randomized Trial of Intraarterial Treatment for Acute Ischemic Stroke

Relationship Between Inflammation and Benefits of Early High-Dose Rosuvastatin on CIN in ACS Patients

DCB vs Standard PTA for the Treatment of Superficial Femoral and-or Popliteal PAD

Stent Coverage and Neointimal Proliferation in BMS Postdilated With a Paclitaxel-Eluting Balloon vs EES

ACS 2014: Unmet Needs

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content